Oregon Administrative Rules › Chapter 415 - OREGON HEALTH AUTHORITY, HEALTH SYSTEMS DIVISION: ADDICTION SERVICES › Division 20 - STANDARDS FOR OUTPATIENT OPIOID TREATMENT PROGRAMS › Section 415-020-0005 - Definitions

Current through Register Vol. 63, No. 7, July 1, 2024
(1) "Accreditation"
			 means the process of review and acceptance by an accreditation body.
(2) "Accreditation Body" means an
			 organization that has been approved by the Substance Abuse and Mental Health
			 Services Administration (SAMHSA) to accredit opioid treatment programs that use
			 opioid agonist treatment medications.
(3) "The ASAM Criteria" means the criteria in
			 the Third edition of The American Society of Addiction Medicine (ASAM) for the
			 assessment, level of care placement and treatment of addictive,
			 substance-related, and co-occurring conditions. The ASAM Criteria is a clinical
			 guide to developing patient-centered service plans and making objective
			 decisions about admission, continuing care, and transfer or discharge for
			 individuals. The ASAM Criteria is incorporated by reference in these
			 rules.
(4) "ASAM Level of Care"
			 means one of several discrete intensities of services and supports, as
			 described within The ASAM Criteria, Third Edition, within a substance use
			 disorders program that are delivered in a structured, programmatic fashion, by
			 a Division certified outpatient or licensed residential provider.
(5) "Assessment" means the process of
			 obtaining sufficient information through a face-to-face interview to determine
			 a diagnosis and to plan individualized services and supports. For residential
			 substance use disorder treatment programs, the assessment is multidimensional
			 and consistent with The ASAM Criteria third edition
(6) "Certificate" means the document or
			 documents issued by the Division, which identifies and declares certification
			 of a provider pursuant to OAR 309-008-0100  to 309-008-1600. A letter
			 accompanying issuance of the certificate shall detail the scope,
The
			 ASAM Criteria
level of care and approved service delivery locations of
			 the certificate.
(7) "Community
			 Mental Health Program (CMHP)" means the organization of various services for
			 individuals with a mental health diagnosis or addictive disorders operated by
			 or contractually affiliated with a local mental health authority and operated
			 in a specific geographic area of the state under an agreement with the Division
			 pursuant to OAR chapter 309, division 014.
(8) "Comprehensive maintenance treatment"
			 means opioid agonist medication treatment that includes a broad range of
			 clinically appropriate medical and rehabilitative services.
(9) "Diversion Control Plan" means a plan
			 implemented by the opioid treatment program that contains specific measures to
			 reduce the possibility of diversion of controlled substances from legitimate
			 treatment use.
(10) "Division"
			 means the Health Systems Division of the Oregon Health Authority (OHA) or its
			 designee.
(11) "Employee" means an
			 individual who provides a program service or who takes part in a program
			 service and who receives wages, a salary, or is otherwise paid by the program
			 for providing the service.
(12)
			 "Federal Protocols" means the standards established by the United States
			 Secretary of Health and Human Services that determines whether an opioid
			 treatment program is qualified to engage in opioid treatment.
(13) "Interim Maintenance Treatment" means
			 treatment provided in conjunction with appropriate medical services while a
			 patient is awaiting transfer to a program that provides comprehensive
			 maintenance treatment.
(14) "Level
			 of Care" means the type, frequency, and duration of medically necessary
			 services provided from the most integrated setting to the most restrictive and
			 intensive inpatient setting.
(15)
			 "Maintenance Treatment" means the administration of an opioid agonist treatment
			 medication at stable dosage levels for a period longer than 21 days.
(16) "Medical Director" means a physician
			 licensed to practice medicine in the State of Oregon who is designated by the
			 opioid treatment program to be responsible for the program's medical
			 services.
(17) "Medically
			 Supervised Withdrawal" means the administration of an opioid agonist treatment
			 medication in decreasing doses to an individual to alleviate adverse physical
			 or psychological effects incident to withdrawal from the continuous or
			 sustained use of an opioid drug and as a method of bringing the individual to a
			 drug free state.
(18) "Medically
			 Supervised Withdrawal Treatment" means treatment for a period of more than 30
			 days but not exceeding 180 days.
(19) "Medical Professional" means a medical
			 or osteopathic physician, physician's assistant licensed by the Board of
			 Medical Examiners, or a registered nurse or nurse practitioner licensed by the
			 Board of Nursing.
(20) "Opiate
			 Addiction" means a cluster of cognitive, behavioral, and physiological symptoms
			 in which the individual continues use of opiates despite significant
			 opiate-induced problems. Opiate addiction is characterized by repeated
			 self-administration that usually results in tolerance, withdrawal symptoms, and
			 compulsive drug taking.
(21)
			 "Opioid Agonist Medication" means any drug that is approved by the Food and
			 Drug Administration under Section 505 of Federal Food, Drug, and Cosmetic Act
			 (21 U.S.C.
			 355) for use in the treatment of opiate
			 addiction.
(22) "Opioid Treatment
			 Program (OTP) means a program that dispenses and administers opioid agonist
			 medications in conjunction with appropriate counseling, supportive, and medical
			 services.
(23) "Patient" means any
			 individual who receives services in an opioid treatment program.
(24) "Patient Record" means the official
			 legal written file for each patient, containing all the information required to
			 demonstrate compliance with these rules. Information in program records
			 maintained in electronic format must be able to be produced in a printed form,
			 authenticated by signature, whether physical or digital, and date of the person
			 who provided the service, and placed in the patient record.
(25) "Program" means an organized system of
			 services and supports delivered by a provider designed to address the treatment
			 needs of individuals and families.
(26) "Quality Assurance" means the process of
			 objectively and systematically monitoring and evaluating the appropriateness of
			 patient care to identify and resolve identified problems.
(27) "Rehabilitation" means those services,
			 such as vocational rehabilitation or academic education, which assist in
			 overcoming the problems associated with drug abuse or drug dependence and which
			 enable the patient to function at their highest potential.
(28) "State Opioid Treatment Authority" means
			 the State Opioid Treatment Authority designated pursuant to
			 section
			 409 of
			 Public Law
			 92-255, the Drug Abuse Office and Treatment Act of
			 1972, or in lieu thereof, any other State authority designated by the Governor
			 for purposes of exercising the authority under this section. The State Opioid
			 Treatment Authority for Oregon is the Oregon Health Authority designee to serve
			 in that role.
(29) "Treatment"
			 means the specific medical and non-medical therapeutic techniques employed to
			 assist the patient in recovering from drug abuse or drug dependence.
(30) "Urinalysis Test" means a sensitive,
			 rapid, and inexpensive immunoassay screen that identifies the presence of a
			 specific drug or metabolite in a urine specimen to eliminate "true negative"
			 specimens from further consideration.
(31) "Volunteer" means a person who performs
			 a service willingly and without pay.
Statutory/Other Authority: ORS
				  430.256
Statutes/Other Implemented: ORS
				  430.010(4)(b)
				  & 430.560 - 430.590